Neonatal Sepsis

Overview & Definition

Neonatal sepsis is a systemic inflammatory response syndrome (SIRS) in response to a documented or suspected infection occurring within the first 28 days of life. It is one of the leading causes of neonatal mortality worldwide, accounting for an estimated 1 million neonatal deaths each year globally, the majority in low- and middle-income countries.^[5][10]

The clinical skill is not the diagnosis (which is syndromic) but three things: (1) recognising that an unwell neonate may be septic — the presentation is so non-specific that any deviation from normal feeding, temperature, alertness or breathing pattern in the first 28 days should trigger a sepsis evaluation; (2) stratifying risk by timing (early- vs late-onset), maternal risk factors and gestation; (3) delivering empirical IV antibiotics within 1 hour of suspicion, with cultures drawn beforehand — every hour of delay measurably increases mortality.^[4][6]

Neonatal sepsis sits within a broader differential that includes focal neonatal infections (pneumonia, meningitis, osteomyelitis, omphalitis, conjunctivitis, necrotising enterocolitis) and must be distinguished from non-infective mimics — most importantly respiratory distress syndrome (RDS), congenital heart disease, inborn errors of metabolism and congenital (TORCH) infection.^[2]

Classification

By timing of onset (the classification that decides empirical antibiotics):^[3][1]

• Early-onset sepsis (EOS) — onset within the first 72 hours of life (UK NICE / international convention) or, in the AAP/CDC convention, the first 7 days of life. Caused by organisms acquired vertically, ascending from the maternal genital tract either in utero (after prolonged rupture of membranes, chorioamnionitis) or during passage through the birth canal. The 'big three' organisms are Group B Streptococcus (GBS, Streptococcus agalactiae), E coli (especially K1 capsular type), and Listeria monocytogenes. In low- and middle-income countries, Klebsiella pneumoniae and other Gram-negatives additionally dominate.
• Late-onset sepsis (LOS) — onset after 72 hours (UK) or after 7 days (US convention). Acquired horizontally — from the hands of carers, contaminated equipment, central venous catheters, total parenteral nutrition (TPN), mechanical ventilation, or the community. The predominant organisms are coagulase-negative staphylococci (CoNS, mostly Staphylococcus epidermidis) — classically line-associated, Staphylococcus aureus (including MRSA), Klebsiella, E coli, Pseudomonas, and — in VLBW infants — Candida. ^[1]

Enlarge

By clinical syndrome — neonatal sepsis may present as: isolated septicaemia; septicaemia with pneumonia, meningitis, osteomyelitis or septic arthritis, omphalitis (umbilical infection), conjunctivitis, or necrotising enterocolitis. Focal signs help direct investigations and broaden empirical cover. ^[1]

By severity — unlike sepsis in older patients, there is no universally accepted definition of neonatal sepsis, which itself complicates severity grading.^[4] Operationally, septic shock means tissue perfusion and haemodynamics that remain inadequate after initial fluid resuscitation, at which point vasoactive/inotropic agents are indicated.^[15] NICU illness severity is scored with SNAPPE-II (Score for Neonatal Acute Physiology with Perinatal Extension-II): 6 physiologic items plus points for birth weight, low Apgar score and small for gestational age (9 items total), empirically validated against in-hospital mortality (area under the ROC curve 0.91).^[12] In neonates with sepsis, a SNAPPE-II cut-off of 20 or more predicted mortality with sensitivity 74.5% and negative predictive value 87.7%, irrespective of blood-culture result.^[16]

Epidemiology & Risk Factors

Neonatal sepsis is a leading infectious cause of neonatal death worldwide.^[5][10]

Maternal and perinatal risk factors:^[7][11]

• Maternal GBS colonisation of the genitourinary and gastrointestinal tracts — the primary risk factor for early-onset GBS disease. Approximately 50% of colonised women transmit GBS to their newborn, and without intrapartum antibiotic prophylaxis 1-2% of those newborns develop early-onset disease.^[7]
• Intraamniotic infection (chorioamnionitis) — suspected or confirmed — and prolonged rupture of membranes: confirmed ROM for over 18 hours before a preterm birth or over 24 hours before a term birth are risk factors in the UK framework.^[11]
• Gestation under 37 weeks and very low birth weight — listed among the additional risk factors for early-onset GBS disease.^[7]
• Young maternal age and black maternal race — additional risk factors for early-onset GBS disease.^[7]

Late-onset risk factors:^[4]

• Central venous catheter (umbilical, peripherally inserted central, Broviac/Hickman) — accounts for the dominance of CoNS in LOS.
• Total parenteral nutrition (TPN) including lipid emulsion — promotes coagulase-negative staph and Candida.
• Mechanical ventilation and endotracheal tubes.
• Prolonged hospital stay (NICU, special care baby unit).
• Surgical procedures (NEC, abdominal wall defects).
• Formula feeding (versus breast milk — protects via secretory IgA, lactoferrin, oligosaccharides).
• Invasive procedures, parenteral medications, inadequate hand hygiene. ^[1]

Pathophysiology

The neonate — particularly the preterm — is immunocompromised by definition. Multiple arms of innate and adaptive immunity are functionally immature:^[1][4]

Quantitative and qualitative neutrophil deficiency. Neonatal neutrophils show impaired chemotaxis, reduced phagocytosis, and a defective oxidative (respiratory) burst. Neonatal neutrophil stores in the bone marrow are also small, so a septic neonate quickly exhausts neutrophil reserves — the leukopenia/neutropenia of neonatal sepsis is itself a poor prognostic marker. The immature-to-total (I:T) neutrophil ratio over 0.2 reflects the bone marrow pouring band forms into circulation. ^[1]

Immunoglobulin deficiency. IgG crosses the placenta actively via FcRn receptor, but most transfer occurs in the third trimester — a baby born before 32-34 weeks has substantially lower IgG than a term baby. IgM does not cross the placenta (it is pentameric), and the neonate cannot mount a brisk IgM response to a new antigen. Secretory IgA is absent from the gut unless breastfed. ^[1]

Complement immaturity. Neonatal C3, factor B, and alternative pathway activity are approximately half of adult values, limiting opsonisation of organisms such as GBS. ^[1]

Pattern-recognition receptor immaturity. Toll-like receptor (TLR) expression, particularly TLR2 and TLR4 on neutrophils and antigen-presenting cells, is reduced; downstream signalling (NF-kB activation, cytokine release) is blunted. This hypo-inflammatory early phase can rapidly tip into a hyper-inflammatory late phase as cytokines accumulate.^[4]

Barrier immaturity. The skin is thin and easily breached (especially at the umbilicus and around central lines); the gut mucosal barrier is immature, allowing bacterial translocation; the blood-brain barrier is also immature, partly explaining why neonatal sepsis seeds the meninges so readily (meningitis complicates 10-30% of EOS).^[3]

Route of acquisition drives the organism: ^[1]

• EOS — vertical transmission. Organisms ascend from the vagina through ruptured or even intact membranes, colonise the amniotic cavity, and are aspirated or swallowed by the fetus, seeding the lungs and bloodstream. Alternatively, the neonate is colonised during passage through the birth canal and develops bacteraemia shortly after birth. The causative organisms reflect the maternal vaginal/rectal flora — hence GBS, E coli K1, Listeria.^[8]
• LOS — horizontal/nosocomial transmission. Organisms reach the neonate via the hands of carers, contaminated equipment, central venous catheters, endotracheal tubes, or feed. The biofilm-forming capacity of CoNS explains its dominance in line-associated sepsis.^[4]

Once bacteraemic, organisms multiply, triggering a cytokine cascade — IL-6, IL-1beta, TNF-alpha, IL-8 — that produces vasodilation, capillary leak, myocardial depression, disseminated intravascular coagulation (DIC), and ultimately multi-organ dysfunction syndrome (MODS). The clinical phenotype is shock, respiratory failure, coagulopathy, metabolic acidosis, hypoglycaemia and hypothermia.^[1]

Enlarge

Clinical Presentation

The single most important fact about neonatal sepsis is that the presentation is non-specific. A neonate cannot localise symptoms. Any one of the following — alone or in combination — in the first 28 days should trigger a sepsis evaluation:^[1][1]

^{[11] [3]}

Atypical presentation in the premature / VLBW neonate — apnoea, temperature instability, glucose instability, feeding intolerance, or an unexplained rise in ventilator/oxygen requirements may be the only signs. Hypothermia in a preterm is more ominous than fever.^[4]

Differential Diagnosis

Neonatal sepsis has no pathognomonic sign, so the differential is broad and the source of the pathogen matters for framing it:^[3]

• Subclinical versus focal versus systemic infection — the clinical manifestations of neonatal sepsis range from subclinical infection to severe manifestations of focal or systemic disease; pneumonia and meningitis are the classic focal presentations, and the two may coexist with bacteraemia.^[3]
• Source of the pathogen frames the differential — an in-utero infection, acquisition from maternal flora, or postnatal acquisition from the hospital or community each point to different organisms and to different non-infective mimics. Timing of exposure, inoculum size, immune status of the infant and virulence of the causative agent all influence the clinical expression.^[3]
• Culture-negative sepsis — clinically, there is often little difference between sepsis caused by an identified pathogen and sepsis caused by an unknown pathogen, so a negative culture does not exclude sepsis; the diagnostic standard blood culture has performance limitations, and improved diagnostics are needed.^[3][4]
• Premature infants with prolonged hospital stays and invasive procedures — consider hospital-acquired infection alongside non-infective deterioration; these infants are at increased risk of hospital-acquired infections.^[3]

The practical rule stands: when infection cannot be excluded in an unwell neonate, treat empirically while investigations proceed — antimicrobial therapy and supportive care remain the principal components of treatment.^[4]

Clinical & Bedside Assessment

ABCDE systematic assessment:^[1]

• Airway — patency; secretions; meconium.
• Breathing — rate (normal neonate 40-60/min; tachypnoea over 60, apnoea); effort (grunting, nasal flaring, subcostal/intercostal/sternal recession); auscultation (symmetry, crackles, wheeze); SpO2 (target 91-95% in preterm, 95-100% in term; differential pre- and post-ductal if congenital heart disease suspected); work of breathing.
• Circulation — heart rate (normal 110-160; tachycardia over 160, bradycardia under 100 ominous); capillary refill (central sternum, normal under 2 s; peripheral toe, normal under 3 s — over 3 s is abnormal); pulses (bound femorals to exclude coarctation); blood pressure (mean BP approximately gestational age in weeks; hypotension a late sign); skin colour (pallor, mottling, acrocyanosis, central cyanosis).
• Disability — tone, alertness, activity, seizures; anterior fontanelle (flat, sunken, bulging); pupils; AVPU/GCS.
• Exposure — full head-to-toe: skin (pustules, cellulitis, petechiae/purpura suggesting DIC), umbilicus (redness, discharge — omphalitis), eyes (conjunctival discharge), joints and long bones (warmth, swelling, pseudoparalysis — reduced movement of a limb suggests osteomyelitis or septic arthritis), abdomen (distension, tenderness, hepatosplenomegaly). ^[1]

Look for shock: tachycardia disproportionate to fever, cold peripheries with central pallor, prolonged capillary refill, weak pulses, mottled skin, oliguria, altered sensorium, hypotension. Hypotension is a late sign in neonates — perfusion must be assessed early.^[1]

Calculate weight-based doses for every drug; neonatal doses are per kg and often per gestational age. ^[1]

Investigations

Take the cultures BEFORE antibiotics. Every minute of antibiotic exposure lowers the yield of the blood culture. The minimal septic screen in a suspected neonatal sepsis case consists of:^[6][1]

Blood

• Blood culture (gold standard) — aseptic venepuncture, 1 mL of blood, into aerobic and anaerobic paediatric bottles; the single most important diagnostic test. Approximately 1-10% of clinically diagnosed neonatal sepsis is culture-positive.
• CRP (C-reactive protein) — acute-phase reactant; rises after 12-24 hours. A single CRP has limited sensitivity early; serial CRP at 24 and 48 hours improves diagnostic performance (CRP over 10 mg/L supportive, two normal CRPs 24 h apart have high negative predictive value for stopping antibiotics).
• Procalcitonin — rises earlier than CRP (within 6 hours); useful in early EOS.
• Presepsin (sCD14-ST) — novel early marker with high sensitivity for EOS; meta-analysis shows superior diagnostic accuracy to CRP and procalcitonin.^[9]
• Full blood count — leukopenia under 5,000 or leukocytosis over 25,000; neutropenia (absolute neutrophil count) under 1,500; thrombocytopenia under 100,000. Hypoproliferative indices suggest bone marrow exhaustion (severe sepsis).
• Immature:Total (I:T) neutrophil ratio — over 0.2 is supportive of sepsis; over 0.3 strongly supportive. Use Manroe / Mouzinho nomograms for gestation-specific reference ranges.
• Blood gas — venous/arterial: metabolic acidosis (base deficit over 10), hypercapnia, hypoxaemia; serum lactate over 2 mmol/L suggests tissue hypoperfusion.
• Glucose — hypoglycaemia common.
• U&E, LFTs, coagulation (PT, aPTT, fibrinogen) — to detect AKI, hepatitis, DIC (prolonged PT/aPTT, low fibrinogen, raised D-dimer).

Lumbar puncture (when stable)

• CSF — microscopy (cell count, differential), protein (raised in neonate over 1.0 g/L), glucose (low, under 0.6 of blood glucose), Gram stain, culture, and where available PCR for HSV and enterovirus.
• Indications: any neonate with EOS, abnormal neurological signs, seizures, bulging fontanelle, or positive blood culture with organism known to seed meninges (GBS, E coli, Listeria).
• Defer if unstable — coagulopathy (platelets under 50,000 or PT over twice normal), cardiorespiratory instability, raised ICP — start antibiotics first, do LP when stabilised. ^[1]

Urine

• Culture — collected by suprapubic aspirate (SPA) or urethral catheterisation. Bag urine is NOT acceptable (contaminated by skin flora). Any growth from SPA is significant; catheter over 10,000 CFU/mL.
• More important in late-onset sepsis (UTI in neonate often co-presents).

Imaging

• Chest X-ray — pneumonia, RDS, effusion, heart size.
• Abdominal X-ray — if NEC suspected (pneumatosis intestinalis, portal venous gas).

Rapid pathogen tests

• GBS PCR / latex agglutination on CSF or urine; HSV PCR on CSF; enterovirus PCR.

Maternal and perinatal data

• GBS status (vaginal-rectal swab at 35-37 weeks), intrapartum fever, duration of ROM, antenatal antibiotics, gestation, birth weight, Apgars.

Named scoring tools

^{[1] [9] [13] [12] [16]}

Management — Resuscitation

Enlarge

Time-critical. If a baby needs antibiotic treatment, give it as soon as possible and always within 1 hour of the decision to treat; with any red flag (or two or more non-red-flag factors), do not wait for test results before starting.^[11]

1. ABCDE: secure airway and breathing — give oxygen for hypoxia and escalate to mechanical ventilation for babies who need it (a red-flag clinical indicator in its own right).^[11]
2. Empirical broad-spectrum IV antibiotics as soon as possible, always within 1 hour of the decision to treat, guided by the NG195 risk-factor and clinical-indicator framework.^[11]
3. Early recognition plus rapid fluid resuscitation — the key tenets of care are early recognition of potential sepsis, rapid intervention with appropriate fluids to restore adequate tissue perfusion, and empiric antibiotics to cover likely pathogens.^[15]
4. Vasoactive/inotropic support — recommended if tissue perfusion and haemodynamics remain inadequate following initial fluid resuscitation; controversy persists over the optimal resuscitation fluid volume and type.^[15]
5. Supportive care alongside antimicrobial therapy — these remain the principal components of neonatal sepsis treatment; refine basic neonatal care to prevent sepsis through education and quality improvement.^[4]
6. Antimicrobial stewardship from the outset — decide early whether the probability of sepsis justifies continuing: antimicrobial therapy should be discontinued at 48 hours in clinical situations in which the probability of sepsis is low, because prolonged empirical broad-spectrum treatment (5 days or more) is associated with higher risks of late-onset sepsis, necrotising enterocolitis and mortality.^[6]
7. Therapeutic drug monitoring for babies receiving gentamicin, per the NG195 monitoring recommendations.^[11]

Surviving Sepsis Campaign paediatric 2020 — the international panel issued 77 statements on the management and resuscitation of children with septic shock and sepsis-associated organ dysfunction (six strong recommendations, 52 weak recommendations, nine best-practice statements), explicitly acknowledging that most aspects of care rest on relatively low-quality evidence.^[17]

Management — Definitive & Stepwise

Empirical antibiotics are timing- and risk-driven:^[1][6][1]

Empirical antibiotic regimens by syndrome

Doses are the NICE NG195 recommended regimens — always verify against the current BNF for Children / NeoFax / local unit policy and adjust for gestational age and renal function. ^[11]

Duration of therapy

• Stop at 48 hours when the probability of sepsis is low — antimicrobial therapy should be discontinued at 48 hours in clinical situations in which the probability of sepsis is low, because clinicians otherwise treat well-appearing infants for extended periods even when cultures are negative.^[6]
• Prolonged empirical broad-spectrum treatment carries harm — 5 days or more of empirical broad-spectrum antibiotics in preterm infants is associated with higher risks of late-onset sepsis, necrotising enterocolitis and mortality.^[6]
• GBS meningitis — benzylpenicillin normally for at least 14 days, with gentamicin.^[11]
• Narrow once identified — once a pathogen is identified, antimicrobial therapy should be narrowed (unless synergism is needed).^[6]

Source control

• Remove infected central venous catheters (especially with CoNS, S aureus, Candida, Gram-negative bacteraemia) — bacteraemia persisting over 24-72 h despite antibiotics is an indication for line removal.
• Drain focal collections (empyema, abscess, septic arthritis). ^[1]

Adjunctive and supportive therapy

• IVIG — not recommended as routine adjunct: among neonates with sepsis, standard polyclonal IVIG does not reduce mortality (RR 1.00, 95% CI 0.92 to 1.08; five trials, n = 3667); monoclonal IVIG remains experimental.^[14]
• Other adjuncts remain unproven — corticosteroids, IVIG, methylene blue and vitamin C have been suggested with theoretical benefit, but definitive recommendations are not yet supported by research reports; several are the subject of ongoing trials.^[15]
• The mainstay stays antimicrobial therapy plus supportive care, with judicious antimicrobial use — refining basic neonatal care to prevent sepsis through education and quality improvement remains paramount.^[4][3]

Prevention (key exam topic)

^[1]

Maternal intrapartum antibiotic prophylaxis (IAP) for GBS:^[7][8]

• Screening window — ACOG now recommends universal GBS screening between 36 0/7 and 37 6/7 weeks of gestation (the 2010 CDC guideline used 35-37 weeks); all women with a positive vaginal-rectal culture should receive intrapartum antibiotic prophylaxis unless a prelabour caesarean birth is performed with intact membranes.^[7]
• Indication — the primary prevention targets are women colonised with GBS: universal prenatal screening by vaginal-rectal culture, correct specimen collection and processing, appropriate implementation of intrapartum antibiotic prophylaxis, and coordination with paediatric care providers.^[7]
• Drug — intravenous penicillin G is the chemoprophylaxis agent; the 2010 CDC revision specifically included a change in the recommended dose of penicillin-G for chemoprophylaxis and updated prophylaxis regimens for women with penicillin allergy — check the current CDC/ACOG regimen rather than relying on remembered doses.^[8]
• Timing — a shorter duration of intrapartum antibiotics is less effective than 4 or more hours of prophylaxis, although even 2 hours of exposure reduces GBS vaginal colony counts and decreases the frequency of a clinical neonatal sepsis diagnosis; obstetric interventions should not be delayed solely to provide 4 hours of antibiotic administration before birth.^[7]
• Effect — universal screening at 35-37 weeks' gestation plus intrapartum antibiotic prophylaxis has resulted in substantial reductions in the burden of early-onset GBS disease among newborns; maternal colonisation rates remain unchanged since the 1970s, so screening and prophylaxis remain the cornerstones of prevention in the absence of a licensed GBS vaccine.^[8]

Specific Subtypes & Scenarios

• Group B Streptococcal sepsis — the prototype EOS organism; early-onset disease presents as pneumonia and/or septicaemia within 24-72 h, late-onset GBS presents as bacteraemia, meningitis, osteomyelitis or septic arthritis. Maternal colonisation rates are unchanged since the 1970s, and universal screening plus intrapartum antibiotic prophylaxis has brought about substantial reductions in early-onset GBS disease.^[8]
• Gram-negative (E coli K1, Klebsiella) sepsis — higher case-fatality; often complicated by meningitis (especially E coli K1); in LMIC these organisms are dominant and frequently ESBL-producing, requiring piperacillin-tazobactam or carbapenem empirical cover.^[1]
• Listeria monocytogenes — acquired from unpasteurised dairy, soft cheese, deli meats, contaminated refrigerated foods; causes granulomatosis infantiseptica (disseminated abscesses with characteristic granulomas); treatment is ampicillin with gentamicin synergy; cephalosporins do NOT cover Listeria.
• Coagulase-negative staphylococcal (CoNS) sepsis — typically line-associated in VLBW preterm infants on TPN; biofilm formation makes eradication difficult without line removal; treat with vancomycin and remove the line if persistent bacteraemia.
• Staphylococcus aureus sepsis — including MRSA; more aggressive, may cause pneumatoceles, osteomyelitis, skin/soft tissue abscesses, scalded skin syndrome; cover with vancomycin (MRSA) or flucloxacillin (MSSA).
• Candida sepsis — VLBW/ELBW infants on broad-spectrum antibiotics, TPN and central lines; fluconazole first-line, amphotericin B if resistant; high mortality and neurodevelopmental sequelae — remove central line.
• Omphalitis (umbilical sepsis) — S aureus, S pyogenes, Gram-negatives, rarely Clostridium tetani (neonatal tetanus in unvaccinated communities); signs: redness, discharge, bleeding from cord; can spread rapidly to abdominal wall and peritonitis — treat aggressively.
• Neonatal tetanus — Clostridium tetani via umbilical stump in unhygienic delivery, unvaccinated mother; presents 3-14 days after birth with trismus, spasms, opisthotonos, inability to suck; treat with human tetanus immunoglobulin, IV penicillin / metronidazole, muscle relaxants, ventilation, and prevent with maternal tetanus toxoid vaccination.
• Necrotising enterocolitis (NEC) — overlaps with sepsis; triad of feeding intolerance, abdominal distension, bloody stools; pneumatosis intestinalis on AXR; broad-spectrum antibiotics (ampicillin + gentamicin + metronidazole); surgery for perforation.
• Osteomyelitis and septic arthritis in the neonate — S aureus, GBS; classically presents as pseudoparalysis (refusal to move a limb), swelling, irritability on handling; multi-focal in neonate due to intra-articular metaphyseal blood supply; treat with prolonged IV antibiotics.

Complications & Pitfalls

Acute:

• Septic shock with multi-organ dysfunction syndrome (MODS).
• DIC with petechiae, purpura, bleeding from puncture sites, intracranial haemorrhage.
• ARDS, pulmonary hypertension, respiratory failure.
• Acute kidney injury from shock and nephrotoxic drugs.
• Necrotising enterocolitis.
• Electrolyte and metabolic derangements: hypoglycaemia, hypocalcaemia, metabolic acidosis, SIADH. ^[1]

Long-term (especially after meningitis):

• Hearing loss (mandatory pre-discharge hearing screen / ABR).
• Cerebral palsy (periventricular leukomalacia).
• Neurodevelopmental delay, cognitive impairment.
• Post-meningitic hydrocephalus, epilepsy, cortical blindness. ^[1]

Classic pitfalls:^[4][1]

• Delaying antibiotics while waiting for cultures or LP — the single biggest cause of preventable mortality.
• Treating the fever, missing sepsis — non-specific signs attributed to "cold", "feeding problem", or "jaundice".
• Accepting a bag urine as a urine culture — contaminated; leads to false-positive cultures and unnecessary antibiotics.
• Forgetting Listeria — covers only with ampicillin, not cephalosporins; consider in maternal ingestion of unpasteurised foods.
• Not removing an infected central line — bacteraemia with CoNS, S aureus, Candida and Gram-negatives often persists until line is out.
• Over-treating with prolonged antibiotics for culture-negative illness — drives resistance and gut dysbiosis.
• Missing meningitis because the fontanelle is soft or LP was deferred — repeat LP / image if clinical suspicion persists.

Prognosis & Disposition

Term infant with early appropriate therapy: excellent — most recover without sequelae. ^[1]

Adverse prognostic markers:^[3][5]

• Prematurity / LBW / VLBW / ELBW.
• Neutropenia (ANC under 1,000) — bone marrow exhaustion; poor outcome.
• Persistent hypotension, acidosis (base deficit over 10), high lactate.
• Multi-organ failure.
• Gram-negative bacteraemia (higher mortality than GBS).
• Delay to antibiotic initiation — every hour of delay beyond the first hour increases mortality.

Mortality: 10-30% overall, 30-50% in VLBW; GBS meningitis approximately 10% mortality, Gram-negative meningitis 20-40% mortality.^[5]

Neurological sequelae after neonatal meningitis: approximately 30-50% — hearing loss, cerebral palsy, cognitive impairment, epilepsy, hydrocephalus, blindness.^[3]

Disposition: all suspected neonatal sepsis cases require admission to a neonatal unit (special care baby unit or NICU per acuity) for IV antibiotics and monitoring; severe cases to NICU for ventilation and inotropes. Step-down to SCBU when stable, afebrile, feeding, culture-negative at 48 h. Hearing screen before discharge if meningitis. ^[1]

Special Populations

• Premature / VLBW — early-onset sepsis remains one of the most common causes of neonatal morbidity and mortality in the preterm population; prolonged hospital stays and invasive procedures place these infants at increased risk of hospital-acquired (late-onset) infection, in which coagulase-negative staphylococci comprise the majority of cases.^[6][1]
• Premature and late-onset groups lack a risk calculator — a tool similar to the sepsis calculator does not exist for preterm infants or late-onset sepsis, groups for which antibiotic stewardship is not as well practised.^[1]
• Well-appearing infant with maternal risk factors — identification of at-risk neonates rests on a constellation of perinatal risk factors that are neither sensitive nor specific, and diagnostic tests have poor positive predictive accuracy, so clinicians often treat well-appearing infants for extended periods even when cultures are negative; use the NG195 risk-factor/clinical-indicator framework and the quantitative EOS risk model to target evaluation.^[6][13]
• Babies receiving gentamicin — NG195 recommends therapeutic drug monitoring (trough concentrations) for babies receiving gentamicin.^[11]

Evidence, Guidelines & Regional Differences

Key landmark guidelines and evidence:^[3][6][1]

• AAP clinical report (Polin 2012) — risk-factor-based identification is neither sensitive nor specific and diagnostic tests have poor positive predictive accuracy; optimal empirical treatment is broad-spectrum agents (ampicillin plus an aminoglycoside); discontinue at 48 hours when the probability of sepsis is low; prolonged empirical therapy (5 days or more) risks late-onset sepsis, NEC and mortality.^[6]
• Quantitative risk-based EOS management (Kuzniewicz/Puopolo 2017, Kaiser Permanente Northern California) — multivariable EOS risk estimates combined with clinical condition reduced laboratory testing and empirical antibiotic use without apparent adverse effects across 204,485 infants born at 35 weeks or later.^[13]
• NICE NG195 (UK) — risk-factor and clinical-indicator framework with red flags; benzylpenicillin 25 mg/kg every 12 hours plus gentamicin 5 mg/kg first-choice for suspected EOS; flucloxacillin plus gentamicin first-line for LOS; amoxicillin plus cefotaxime for meningitis of unknown cause; antibiotics as soon as possible and always within 1 hour of the decision to treat.^[11]
• CDC revised GBS prevention guidelines (Verani 2010) — universal vaginal-rectal GBS screening at 35-37 weeks, intrapartum antibiotic prophylaxis for GBS-positive or risk-factor-positive women; associated with substantial reductions in early-onset GBS disease.^[8]
• ACOG Committee Opinion 797 (2020) — recommends universal GBS screening between 36 0/7 and 37 6/7 weeks of gestation, replacing the obstetric components of the CDC 2010 guideline; prophylaxis of 4 or more hours is more effective than shorter durations.^[7]
• Surviving Sepsis Campaign paediatric 2020 (Weiss et al.) — 77 statements on management and resuscitation of children with septic shock and sepsis-associated organ dysfunction (six strong recommendations, 52 weak, nine best-practice statements), most resting on relatively low-quality evidence.^[17]
• Global burden (Fleischmann-Struzek 2018; Fleischmann 2021) — population-level estimate 2202 cases per 100,000 live births with 11-19% mortality, extrapolating to 3.0 million neonatal sepsis cases globally; updated meta-analysis 2824 per 100,000 live births with 17.6% dying, rising to 3930 per 100,000 in LMICs (2009-2018), with marked heterogeneity between studies.^[10][5]

Exam Pearls

^{[1] [1] [1] [1] [11] [6] [7] [11] [10] [7]}

Exam application bank (NEET-PG / INICET)

One-line answer

Neonatal sepsis is a systemic inflammatory response to a documented or suspected infection in the first 28 days of life. It is the great mimic of neonatology: presentation is non-specific (temperature instability, poor feeding, lethargy, respiratory distress, apnoea). Divided into early-onset sepsis (EOS, within 72 hours or 7 days) — vertically acquired from the maternal genital tract, organisms Group B Streptococcus (GBS), E coli (K1 capsule), Listeria monocytogenes — and late-onset sepsis (LOS, after 72 hours or 7 days) — horizontally/nosocomially acquired, organisms coagulase-negative staphylococci (CoNS, S epidermidis), S aureus (incl MRSA), Klebsiella, E coli, Pseudomonas, Candida. Mortality 10 to 30% overall, higher in premature and LBW infants. Take a blood culture before antibiotics and start empirical IV antibiotics within 1 hour: UK benzylpenicillin + gentamicin (EOS) or fl

Worked stems (answer without another resource)

Stem 1 — Classic presentation. Map symptoms to mechanism; name the first investigation and first treatment step with dose/route if drug therapy is standard. ^[1]

Stem 2 — Unstable / complicated. List red flags that force immediate resuscitation, theatre, ICU, antidote, or reperfusion — and what you do in the first 15 minutes. ^[1]

Stem 3 — Atypical group. Elderly, pregnancy, child, or immunocompromised: how presentation and thresholds change. ^[1]

Stem 4 — Differential trap. Name the three closest mimics and one discriminator for each. ^[1]

Stem 5 — Disposition. Who goes home with safety-netting, who is admitted, who needs HDU/ICU/theatre, and what follow-up is mandatory. ^[1]

Rapid viva checklist

1. Definition + classification
2. Pathophysiology chain
3. Bedside signs / criteria
4. Score with exact components (if any)
5. Emergency bundle
6. Definitive therapy with doses
7. Complications of disease and of treatment
8. Special populations
9. Guideline/trial name if classic
10. Three exam traps

Coverage self-check

If you cannot answer any stem above from this page alone, re-read the matching section — the page is intended to be self-sufficient for final-prof and NEET-PG/INICET questions on Neonatal Sepsis.

References17ShowHide

1. [1]Glaser MA, Hughes LM, Jnah A, et al. Neonatal Sepsis: A Review of Pathophysiology and Current Management Strategies Adv Neonatal Care, 2021.PMID 32956076
2. [2]Raturi A, Chandran S Neonatal Sepsis: Aetiology, Pathophysiology, Diagnostic Advances and Management Strategies Clin Med Insights Pediatr, 2024.PMID 39371316
3. [3]Shane AL, Stoll BJ. Neonatal sepsis Lancet, 2017.PMID 28434651
4. [4]Strunk T, Molloy EJ, Mishra A, et al. Neonatal bacterial sepsis Lancet, 2024.PMID 38944044
5. [5]Fleischmann C, Reichert F, Cassini A, et al. Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis Arch Dis Child, 2021.PMID 33483376
6. [6]Polin RA; Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis Pediatrics, 2012.PMID 22547779
7. [7]American College of Obstetricians and Gynecologists (ACOG) Committee on Obstetric Practice. Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797 Obstet Gynecol, 2020.PMID 31977795
8. [8]Verani JR, McGee L, Schrag SJ; CDC. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010 MMWR Recomm Rep, 2010.PMID 21088663
9. [9]Poggi C, Lucenteforte E, Petri D, et al. Presepsin for the Diagnosis of Neonatal Early-Onset Sepsis: A Systematic Review and Meta-analysis JAMA Pediatr, 2022.PMID 35639395
10. [10]Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, et al. The global burden of paediatric and neonatal sepsis: a systematic review Lancet Respir Med, 2018.PMID 29508706
11. [11]National Institute for Health and Care Excellence. Neonatal infection: antibiotics for prevention and treatment (NICE guideline NG195) NICE, 2021.Source
12. [12]Richardson DK, Corcoran JD, Escobar GJ, et al. SNAP-II and SNAPPE-II: Simplified newborn illness severity and mortality risk scores J Pediatr, 2001.PMID 11148519
13. [13]Kuzniewicz MW, Puopolo KM, Fischer A, et al. A Quantitative, Risk-Based Approach to the Management of Neonatal Early-Onset Sepsis JAMA Pediatr, 2017.PMID 28241253
14. [14]Alejandria MM, Lansang MA, Dans LF, et al. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock Cochrane Database Syst Rev, 2013.PMID 24043371
15. [15]Burgunder L, Heyrend C, Olson J, et al. Medication and Fluid Management of Pediatric Sepsis and Septic Shock Paediatr Drugs, 2022.PMID 35307800
16. [16]Samanta M, Biswas C, Pal NK, et al. Performance of SNAPPE-II score in neonatal sepsis: an experience from a tertiary care center Turk J Pediatr, 2020.PMID 32419410
17. [17]Weiss SL, Peters MJ, Alhazzani W, et al. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children Pediatr Crit Care Med, 2020.PMID 32032273